Inspire Medical Systems, which spun out from Medtronic (NYSE:MDT) in 2007 and creates devices for treating obstructive sleep apnea, said last Friday it is looking to launch an initial public offering that could bring in as much as $86.3 million for the company.
Inspire Medical developed and produces a sleep apnea implant, a pacemaker-like system designed to stimulate nerves to keep airways open during sleep.
The Minneapolis-based company said it plans to offer shares under the NYSE ticker symbol “INSP”.
Last year, the company reported sales of $28.6 million and approximately $22.6 in gross profit, with $17.5 million in net losses, down from a reported $18.5 million in net losses reported in 2016.
The company has not yet said how many shares it plans to float in the offering. BofA Merrill Lynch and Goldman Sachs & Co are acting as underwriters for the offering, according to an SEC filing.
In November 2016, Inspire Medical closed a $37.5 million Series F financing round, as well as announcing the appointment of Marilyn Nelson to the board of directors.
DeviceTalks Minnesota's leadership track is designed to provide attendees with insights on topics such as:
Use code SAVE15 to save 15%!